USFDA completes cGMP inspection at Marksans Pharma’s Goa facility

10 Nov 2025 Evaluate

The U.S. Food and Drug Administration (USFDA) has completed a current Good Manufacturing Practice (cGMP) inspection at the 2nd manufacturing facility of Marksans Pharma located at Verna, Goa. The inspection was held between November 03, 2025 to November 07, 2025. At the conclusion of the inspection, the USFDA issued zero from 483 observation.

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

178.90 -3.15 (-1.73%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×